BeOne Medicines AG

NasdaqGS:ONC Stock Report

Market Cap: US$36.3b

BeOne Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ONC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Jun 26SellUS$933,592John OylerIndividual3,410US$275.10
23 Jun 26SellUS$295,553Wang LaiIndividual1,068US$276.74
23 Jun 26SellUS$356,927Xiaobin WuIndividual1,292US$276.26
16 Jun 26SellUS$361,997Xiaobin WuIndividual1,357US$266.76
16 Jun 26SellUS$980,686John OylerIndividual3,693US$266.69
16 Jun 26SellUS$156,925Chan LeeIndividual590US$265.98
16 Jun 26SellUS$310,236Wang LaiIndividual1,169US$265.39
11 Jun 26SellUS$163,512Xiaobin WuIndividual626US$261.20
11 Jun 26SellUS$110,268Chan LeeIndividual428US$257.64
11 Jun 26SellUS$162,637Aaron RosenbergIndividual631US$257.74
11 Jun 26SellUS$197,318Wang LaiIndividual756US$261.00
11 Jun 26SellUS$43,467Titus BallIndividual169US$257.53
11 Jun 26SellUS$501,355John OylerIndividual1,949US$258.81
08 Jun 26SellUS$1,336,548John OylerIndividual4,940US$271.14
08 Jun 26SellUS$399,738Xiaobin WuIndividual1,484US$270.55
08 Jun 26SellUS$368,247Wang LaiIndividual1,367US$270.73
08 Jun 26SellUS$235,539Chan LeeIndividual871US$271.26
08 Jun 26SellUS$36,901Titus BallIndividual136US$272.08
01 Jun 26SellUS$65,596Qingqing YiIndividual235US$279.13
22 May 26SellUS$65,633Corazon SandersIndividual212US$309.59
22 May 26SellUS$65,636Margaret Han DuganIndividual212US$309.60
22 May 26SellUS$65,617Alessandro RivaIndividual212US$309.51
20 May 26BuyUS$21,914,736Capital Research and Management CompanyCompany72,535.23US$302.13
17 Nov 25SellUS$1,518,303Xiaobin WuIndividual3,991US$382.32
13 Nov 25SellUS$5,846,820Xiaobin WuIndividual16,009US$381.05
09 Sep 25BuyUS$3,034,068Capital Research and Management CompanyCompany67,875.63US$44.70
02 Sep 25SellUS$39,865Titus BallIndividual122US$326.76
11 Aug 25SellUS$15,891,389Capital Research and Management CompanyCompany55,078.47US$288.52
01 Aug 25SellUS$345,659Aaron RosenbergIndividual1,190US$290.47
30 Jul 25SellUS$280,233Chan LeeIndividual920US$304.60

Insider Trading Volume

Insider Buying: ONC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONC?
Owner TypeNumber of SharesOwnership Percentage
Private Companies198,9130.179%
Individual Insiders4,858,8864.37%
Hedge Funds8,881,2937.99%
Public Companies18,938,11917%
General Public21,659,55119.5%
Institutions56,603,91250.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17%
Amgen Inc.
18,938,119US$6.2b0%no data
7.99%
Baker Bros. Advisors LP
8,881,293US$2.9b0.93%14.69%
6.44%
Capital Research and Management Company
7,158,809US$2.3b12.2%0.09%
4.74%
Hillhouse Investment Management, Ltd.
5,271,893US$1.7b0%8.16%
4.48%
PRIMECAP Management Company
4,975,181US$1.6b-0.11%0.99%
3.4%
John Oyler
3,783,222US$1.2b-1.96%no data
3.3%
FMR LLC
3,670,557US$1.2b-7.46%0.05%
2.85%
BlackRock, Inc.
3,169,754US$1.0b-6.3%0.01%
2.67%
China Asset Management Co. Ltd.
2,963,951US$968.8m0.23%0.86%
1.91%
Vanguard Capital Management, LLC
2,126,166US$695.0m3.33%0.01%
1.07%
Norges Bank Investment Management
1,191,543US$389.5m0%0.02%
0.93%
Citadel Advisors LLC
1,032,298US$337.4m93.5%0.22%
0.92%
Hang Seng Investment Management Limited
1,023,378US$334.5m257%1.02%
0.79%
China Universal Asset Management Company Ltd.
880,090US$287.7m0.06%0.83%
0.78%
Temasek Holdings (Private) Limited
862,643US$282.0m-6.19%0.16%
0.77%
ICBC Credit Suisse Fund Management Co., Ltd
858,843US$280.7m0%0.9%
0.69%
T. Rowe Price Group, Inc.
761,477US$248.9m-29%0.02%
0.65%
Xiaodong Wang
722,080US$236.0m0.79%no data
0.56%
Baillie Gifford & Co.
622,456US$203.5m-3.89%0.1%
0.52%
Fullgoal Fund Management Co. Ltd.
578,080US$189.0m0%0.38%
0.5%
UBS Asset Management AG
559,818US$183.0m-0.25%0.01%
0.49%
Vanguard Fiduciary Trust Company
546,072US$178.5m3.89%0.02%
0.48%
Yinhua Fund Management Co., Ltd.
534,100US$174.6m0%0.87%
0.43%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
477,668US$156.1m-0.34%0.03%
0.42%
Artal Group S.A.
465,000US$152.0m-7%2.35%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/24 04:41
End of Day Share Price 2026/07/24 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeOne Medicines AG is covered by 68 analysts. 34 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tianli WenAletheia Analyst Network Limited
Brian SkorneyBaird
Peter LawsonBarclays